These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 6933321)

  • 1. [The use of betamethasone in polychemotherapy of lymphoproliferative diseases].
    Cellerino R; Ambrosetti A; Tummarello D; Perini A; Piga A; Celebrano M
    Minerva Med; 1980 Sep; 71(32):2293-7. PubMed ID: 6933321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Betamethasone in the treatment of acute lymphatic leukosis and other lymphoproliferative diseases].
    Invernizzi R
    Minerva Med; 1980 Nov; 71(44):3247-50. PubMed ID: 6935535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylenetetrahydrofolate reductase C677T polymorphism in adult patients with lymphoproliferative disorders and its effect on chemotherapy.
    Timuragaoglu A; Dizlek S; Uysalgil N; Tosun O; Yamac K
    Ann Hematol; 2006 Dec; 85(12):863-8. PubMed ID: 16944145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fludarabine in the treatment of chronic lymphocytic leukemia and other lymphoproliferative disorders].
    Pawelski S
    Acta Haematol Pol; 1995; 26(3):263-8. PubMed ID: 8525771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control study.
    Bianco E; Marcucci F; Mele A; Musto P; Cotichini R; Sanpaolo MG; Iannitto E; De Renzo A; Martino B; Specchia G; Montanaro M; Barbui AM; Nieddu R; Pagano L; Rapicetta M; Franceschi S; Mandelli F; Pulsoni A;
    Haematologica; 2004 Jan; 89(1):70-6. PubMed ID: 14754608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose ifosfamide in combination with etoposide and epirubicin (IVE) in the treatment of relapsed/refractory Hodgkin's disease and non-Hodgkin's lymphoma: a report on toxicity and efficacy.
    Proctor SJ; Taylor PR; Angus B; Wood K; Lennard AL; Lucraft H; Carey PJ; Stark A; Iqbal A; Haynes A; Russel N; Leonard RC; Culligan D; Conn J; Jackson GH
    Eur J Haematol Suppl; 2001 Jul; 64():28-32. PubMed ID: 11486397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of hexamethylmelamine in refractory Hodgkin's disease, other lymphomas, and chronic lymphocytic leukemia.
    Omura GA; Broun GO; Papps J; Birch R
    Cancer Treat Rep; 1981; 65(11-12):1027-9. PubMed ID: 6794907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Results of therapy in Hodgkin's disease with special reference to polychemotherapy (MOPP)].
    Büchi G; Cervellera M; Vigna-Taglianti G; Denna V; Navone R
    Minerva Med; 1976 Dec; 67(59):3913-20. PubMed ID: 826854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy of malignant lymphomas].
    Huber H; Gattringer C; Lechleitner M; Gyenes T; Frommhold H; Brittinger G; Braunsteiner H
    Wien Klin Wochenschr; 1983 Feb; 95(4):93-112. PubMed ID: 6342274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Leurosine, the 3d alkaloid from Vinca rosea, in the treatmen t of Hodgkin's disease, acute lymphoblastic leukemia and lymphoblastosarcoma].
    Schneider M; Band P; Amiel JL; Schwarzenberg L; Cattan A; Schlumberger JR; Mathé G
    Sem Hop; 1966 Nov; 42(49):2952-4. PubMed ID: 4292621
    [No Abstract]   [Full Text] [Related]  

  • 12. [Chemotherapy of non-hodgkin's lymphomas (author's transl)].
    Fereberger W; Neubauer M
    Acta Med Austriaca; 1981; 8(1):1-6. PubMed ID: 7234308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitoxantrone, vinblastine, and lomustine (CCNU) (MVC): a highly active regimen for advanced and poor-prognosis Hodgkin's disease.
    Wiernik PH; Dutcher JP; Einzig AI; Sparano J; Frank M; Friedenberg W
    Cancer J Sci Am; 1998; 4(4):254-60. PubMed ID: 9689984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comments about use of polychemotherapy MOPP associated with radiotherapy in the treatment of early stages of Hodgkin's disease. Preliminary report of 58 patients (author's transl)].
    Brun B; Alaoui Y; Kuentz M; Baillet F; Maylin C; Vernant JP; Reyes F; Rochant H; Pierquin B; Dreyfus B
    Ann Med Interne (Paris); 1980; 131(4):239-43. PubMed ID: 7425449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Curability of advanced malignant lymphoma under conditions of modern combination chemotherapy].
    Viollier AF; Senn HJ; Obrecht JP
    Schweiz Med Wochenschr; 1978 Dec; 108(49):1958-61. PubMed ID: 749192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab in B-cell disorders other than non-Hodgkin's lymphoma.
    Bosly A; Keating MJ; Stasi R; Bradstock K
    Anticancer Drugs; 2002 Nov; 13 Suppl 2():S25-33. PubMed ID: 12710588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus infection and lymphoproliferative diseases: prospective study on 1,576 patients in France.
    Hausfater P; Cacoub P; Sterkers Y; Thibault V; Amoura Z; Nguyen L; Ghillani P; Leblond V; Piette JC
    Am J Hematol; 2001 Jul; 67(3):168-71. PubMed ID: 11391713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Leukaemias and lymphomas treatment by vindesine. Result of a phase II trial in terms of remission induction (author's transl)].
    Marthé G; Misset JL; de Vassal F; Hayat M; Gouveia J; Machover D; Belpomme D; Schwarzenberg L; Ribaud P; Pico JL; Musset M; Jasmin C; de Luca L
    Nouv Presse Med; 1978 Feb; 7(7):525-8. PubMed ID: 273888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination chemotherapy followed by an immunotoxin (anti-B4-blocked ricin) in patients with indolent lymphoma: results of a phase II study.
    Longo DL; Duffey PL; Gribben JG; Jaffe ES; Curti BD; Gause BL; Janik JE; Braman VM; Esseltine D; Wilson WH; Kaufman D; Wittes RE; Nadler LM; Urba WJ
    Cancer J; 2000; 6(3):146-50. PubMed ID: 10882329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chemotherapy of malignant lymphoma].
    Horikoshi N; Ogawa M
    Gan To Kagaku Ryoho; 1982 Nov; 9(11):1903-10. PubMed ID: 6985187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.